| BOSTON SCIENTIFIC DL-,01 |
| USA |
| Gesundheit |
| US1011371077 / 884113 |
| BSX (Frankfurt) / BSX (NYSE) |
| FRA:BSX, ETR:BSX, BSX:GR, NYSE:BSX |
| S&P500 |
| http://www.bostonscientif.. |
|
Boston Scientific Corporation develops, manufactures, and markets medical devices for interventional medical procedures worldwide. It operates through two primary segments: MedSurg, encompassing Endos..
>Volltext.. |
| 97547.34 Mio. EUR |
| 106272.18 Mio. EUR |
| 17314.17 Mio. EUR |
| 4691 Mio. EUR |
| 2499.45 Mio. EUR |
| 1.69 EUR |
| 10325.54 Mio. EUR |
| 1763.76 Mio. EUR |
| 3910.46 Mio. EUR |
| 0.38 |
| 5.66% |
| 37.85% |
| - |
| - |
| - |
| BOSTON SCIENTIFIC |
| 04.03.26 |
|
||||
|